ÂÜÀòÂÒÂ×

Debora Dumont is an accomplished professional with extensive experience in the life sciences and healthcare sectors. Currently serving as a Board Member at Primmune Therapeutics and Anavo Therapeutics BV, and as a Director at Enhanc3D Genomics Ltd, Debora also co-founded and manages Bioqube Ventures. Previous roles include being a Bestuurder at LIMBURGS KANKERFONDS and Director at BioVille - LSDC NV, along with leadership positions at LRM and Hasselt University-BIOMED. Debora holds a PhD in Biomedical Sciences from Hasselt University and a degree in Bioscience Engineering, specializing in Cell and Gene Technology from KU Leuven.